SLS Sellas Life Sciences Group Inc

P/E --
Forward P/E --
Price/Sales 26.9
Beta 2.425
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 SLS is trading 4.3% down today on profit-taking following a multi-day rally and analyst-driven momentum

SLS is trading 4.3% down at $12.92 as investors lock in profits following a sharp multi-day rally fueled by bullish analyst coverage and anticipation of Phase...

Sellas Gets a 150% Price Target Hike — But Can a Cancer Vaccine Trial Deliver the Goods?

Shares of Sellas Life Sciences surged 8.2% to $14.61 as investors digested a dramatic vote of confidence from Wall Street: Alliance Global analyst James...

🟢 SLS is trading 8.2% up today after Alliance Global raised its price target to $25

SLS is trading 8.2% higher at $14.61 following a significant price target increase from Alliance Global. • Alliance Global raised its price target on Sellas...

🟢 SLS makes sharp 10.3% jump

SLS is trading at $14.63, up 10.3% versus the comparison close of $13.27 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 SLS extends move to 7.0% up

SLS is trading at $14.20, up 7.0% versus the comparison close of $13.27 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 SLS is trading 4.7% up today with no clear new catalyst

SLS is trading 4.7% up now at $13.90 after sharp swings over the past week, including a 24.7% jump on June 29 and a 10.1% drop on July 1. There are no fresh...

🔴 SLS makes sharp 11.4% drop

SLS is trading at $13.08, down 11.4% versus the comparison close of $14.76 during regular trading. This is a price-movement alert; no separate company-specific...

🔴 SLS extends move to 5.4% down

SLS is trading at $13.96, down 5.4% versus the comparison close of $14.76 during pre-market. This is a price-movement alert; no separate company-specific...

🔴 SLS is trading 4.3% down today as traders lock in profits after REGAL trial rally

SLS is trading at $14.12 (4.3% down) as the stock pulls back following a significant multi-day rally driven by Phase 3 REGAL trial optimism. • The stock...

🔴 SLS makes sharp 10.3% drop

SLS is trading at $13.86, down 10.3% versus the comparison close of $15.45 during regular trading. This is a price-movement alert; no separate company-specific...

🔴 SLS is trading 6.2% down today as buyout speculation cools and traders take profits

SLS is trading 6.2% down today at $14.49 as buyout speculation cools and traders take profits following a sharp multi-day rally to 52-week highs. • The stock...

SELLAS Life Sciences Slumps, Erasing Gains as Buyout Speculation Cools

SELLAS Life Sciences shares are retreating from a recent 52-week high. Traders are taking profits as speculation regarding a potential company buyout...

🟢 SLS makes sharp 10.7% jump

SLS is trading at $17.10, up 10.7% versus the comparison close of $15.45 during pre-market. This is a price-movement alert; no separate company-specific...

🟢 SLS is trading 6.22% up today on oncology pipeline optimism and buyout chatter

SLS is trading at $16.41 (6.22% up) as it extends a sharp late-June rally fueled by oncology pipeline optimism and persistent buyout chatter. • The stock has...

Sellas Life Sciences Surges 58% in a Week on Buyout Whispers and a Looming Cancer Trial Verdict — But Is the Market Pricing in a Miracle?

Shares of Sellas Life Sciences shifted sharply higher this week, with the stock rocketing from $8.53 to $13.47 — a 58% gain in five sessions — as two powerful...

🟢 SLS is trading 8.8% up today on buyout speculation and imminent Phase 3 REGAL trial data

SLS is trading 8.8% up at $13.47, extending a sharp multi-session rally as the market anticipates pivotal clinical results. • The price action is driven by...

🟢 SLS surges 5.65% amid buyout speculation and imminent clinical trial readout

• SLS stock is up 5.65% today, driven by heightened speculation of a potential company buyout following recent executive compensation amendments. • Investors...

SELLAS Life Sciences Secures $135.8M Cash, Extending Runway Past Two Years

SELLAS Life Sciences reported a pro forma cash position of approximately $135.8 million as of early June. Recent warrant exercises significantly bolstered this...

🟢 SLS makes sharp 10.3% jump

SLS is trading at $11.61, up 10.3% versus the comparison close of $10.53 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 SLS is trading 6.9% up today as executive contract changes fuel M&A speculation

SLS is trading 6.9% up now at $11.26 after investors react to newly amended executive employment and severance agreements that shift change-of-control benefits...